Top compounds associated with response to RGS17


Feature Type Standardized
Nominal ANOVA
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.21 2e-07
mRNA DMOG GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA neratinib CTRPv2 pan-cancer AAC -0.13 0.0005
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC 0.17 0.0007
mRNA SGX-523 CTRPv2 pan-cancer AAC 0.13 0.0008
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA GDC-0941 GDSC1000 pan-cancer AAC -0.12 0.001
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.11 0.001
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.13 0.002
Download CSV